You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Complications of cancer

Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours

  • Technology appraisal guidance
  • Reference number: TA1034
  • Published:  22 January 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendation
  • 2 Information about anhydrous sodium thiosulfate
  • 3 Committee discussion
  • 4 Implementation
  • 5 Evaluation committee members and NICE project team
  • Update information

Update information

March 2025: we updated section 4 to refer to availability of early funding.

ISBN: 978-1-4731-6788-9


Previous page 5 Evaluation committee members and NICE project team
Back to top